Simple Science

Cutting edge science explained simply

# Health Sciences# Ophthalmology

Retinal Imaging: A New Hope for Neurodegenerative Disease Diagnosis

Using eye health to detect brain diseases like Alzheimer's and Parkinson's.

― 6 min read


Retina's Role in DiseaseRetina's Role in DiseaseDetectionbrain disorders.Eye imaging may reveal early signs of
Table of Contents

Neurodegenerative Diseases are a group of conditions that affect the brain and nervous system, leading to the loss of nerve cells over time. This results in a decline in brain function, impacting memory, movement, and other essential abilities. Two of the most common types of these diseases are Alzheimer's Disease (AD) and Parkinson's Disease (PD). In the UK, around 1 million people are diagnosed with these conditions, and the numbers continue to grow. Sadly, Alzheimer’s Disease was identified as the leading cause of death in England in late 2020. This trend indicates an urgent need for effective treatments and timely methods for diagnosing these diseases.

The Eye and Brain Connection

While some may not think about the eye in connection with the brain, they are closely related. The eye, particularly the retina, acts as a part of the brain and central nervous system. The retina takes light from the environment and converts it into electrical signals. These signals travel through nerve cells to the optic nerve and ultimately reach the part of the brain responsible for vision.

Given the similarities between the eye and the brain in terms of their cell types and responses to damage, the eye provides a unique way to observe changes in the brain related to neurodegenerative diseases. Recent advances in eye health technology indicate that changes in the retina can reveal important information about brain health.

Retinal Imaging and Health

Research has shown that subtle changes in the eye can relate to significant health issues, such as heart disease, strokes, and neurodegenerative diseases. The field of "oculomics" has emerged, focusing on using the eye as an indicator of overall health. By using advanced imaging technology, scientists can detect changes in the retina that may signal the early stages of neurodegenerative diseases like Alzheimer's and Parkinson's.

Some studies have found that specific retinal measurements differ in patients with AD and PD compared to healthy individuals. These measurements include the thickness of various layers in the retina, which can correlate with the overall health of the brain.

Importance of Retinal Diagnostics

Retinal diagnostics offer several advantages for detecting neurodegenerative diseases. They are generally non-invasive, accessible, and less expensive than traditional brain imaging methods. This makes them an attractive option for early detection and monitoring of these diseases.

There is growing evidence suggesting that changes in the thickness of retinal nerve fibers and other cell layers in the retina may reflect broader issues in the brain. Unfortunately, more research is needed to understand how these retinal changes vary across different subtypes of dementia. By identifying which retinal layers are affected by each disease, researchers aim to pinpoint the most effective imaging techniques for diagnosis.

Research Goals

This research aims to gather and analyze information on how retinal imaging techniques can help detect neurodegenerative diseases. The study will focus on mid-to-late-life adults, both healthy individuals and those diagnosed with various forms of dementia, including Alzheimer’s Disease, Dementia with Lewy Bodies, and others.

One key goal is to determine if high-resolution retinal imaging can effectively detect the presence of neurodegenerative diseases based on changes in the retina. A second goal is to identify which specific retinal layers are impacted by different types of dementia. The study will look closely at various aspects of the retina, including blood vessel structure, nerve fiber thickness, and other key features.

Methods

To conduct this research, a thorough search of published studies will be performed using databases like PubMed, Web of Science, and Scopus. Studies included in this review will focus on adults aged 50 and older who have been diagnosed with specific neurodegenerative diseases or are healthy with no cognitive issues. Researchers will also include studies that use at least one type of retinal imaging technique, such as Optical Coherence Tomography (OCT) or Electroretinography (ERG).

The aim is to compare results across different subtypes of neurodegenerative diseases and assess whether the changes observed in the retina align with the changes happening in the brain. By doing this, researchers hope to uncover insights that could lead to improved diagnostic methods.

Data Extraction and Analysis

Once relevant studies are collected, researchers will extract key information, including study design, participant details, and the types of imaging techniques used. They will also assess how the different retinal features correlate with the presence or severity of neurodegenerative diseases.

The data will be analyzed using specialized software. Results will be sorted according to the type of disease, and findings will be summarized in tables and narrative descriptions. This systematic review aims to see if certain retinal imaging methods can effectively highlight differences in disease types or stages.

Assessing Quality of Studies

To ensure the reliability of the findings, researchers will assess the quality of the studies included in the review using a standard method. This assessment will focus on potential biases and the overall reliability of the data presented. Any disagreements in findings will be discussed among the research team, and a senior reviewer will help resolve any significant issues.

Patient and Public Involvement

While this research does not include direct engagement with patients or the public during the study phase, there are plans to share the findings widely once the review is completed. This will include collaboration with dementia charities and presentations at relevant conferences to ensure that the information reaches those who need it.

Ethical Considerations

Since this research only uses already published data and does not involve personal identifiable information, it does not present any immediate ethical concerns. The goal is to gather and analyze existing research to improve understanding and diagnosis of neurodegenerative diseases.

Conclusion

The increase in neurodegenerative diseases places a tremendous burden on patients and their families. There is a pressing need for quicker and more accurate methods of diagnosis. This research aims to gather insights into whether retinal imaging can be used reliably as a diagnostic tool for these conditions.

By focusing on changes in the retina, researchers hope to uncover information that could lead to better early detection and treatment strategies. Ultimately, the findings could have a positive impact on the diagnosis and management of neurodegenerative diseases, helping to improve the quality of life for many individuals affected by these conditions.

Original Source

Title: Using Retinal diagnostics as a Biomarker for Neurodegenerative Diseases: Protocol for a systematic review.

Abstract: IntroductionRetinal neurodegeneration has recently been shown to occur in tandem with neurodegenerative disease. In the expectation that disease modifying treatments for Alzheimers Disease and Parkinsons Disease will soon become available, it will be important to have clinically useful biomarkers for neurodegenerative disease subtyping to guide early diagnosis, inform on prognosis and stratify subgroups for treatment. Understanding differences in detectable retina changes in individuals with different neurodegenerative disease subtypes is therefore fundamental. The emerging field of oculomics posits that systemic and neurodegenerative disease can be characterised using detectable ocular biomarkers within retinal diagnostics. The aim of this review is to compare the performance of common retinal imaging modalities in neurodegenerative disease detection and subtyping. Methods and analysisThis protocol has been developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) guidelines. A comprehensive literature search will be conducted in PubMed, Web of Science, and Scopus. Eligible studies will have reported using retinal diagnostic tools defined as Optical Coherence Tomography (OCT), Optical Coherence Tomography Angiography (OCTA), Colour Fundus Photography (CFP) and Electroretinography (ERG) in individuals with neurodegenerative diseases, including Alzheimers Disease (AD), Parkinsons Disease (PD), Dementia with Lewy Bodies (DLB), Frontotemporal Dementia (FTD), Vascular Dementia (VaD), and Mild Cognitive Impairment (MCI). There will be no time restrictions placed in these searches. Studies not written in English, not peer-reviewed and grey literature will be excluded. Screening for eligible studies and data extraction will be conducted by two independent reviewers, using predefined inclusion criteria. Any disagreements between the reviewers will be settled by discussion, and if required, third senior reviewer arbitration. The systematic review primary outcome is the performance of retinal diagnostics, namely OCT, OCTA, CFP, and ERG in the detection and subtyping of aforementioned neurodegenerative diseases. The secondary outcome is to evaluate the association between changes in retinal diagnostic features (e.g. retinal layer thicknesses) and neurodegenerative disease subtypes. The quality of the included studies will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) tool. A narrative synthesis approach will be used to analyse the results, with meta-analysis performed if there is sufficient data. Ethics and DisseminationEthical approval for this manuscript is not required, as this is a protocol for a systematic review and therefore no data are to be collected. Findings for this systematic review will be disseminated as a peer-reviewed publication and presentations at national and international symposiums including International Lewy body Dementia Conference, International Congress of Parkinsons Disease and Movement Disorders, The Association for Research in Vision and Ophthalmology. PROSPERO Registration NumberCRD42023434024 STRENGTHS AND LIMITATIONS OF THIS STUDY{blacksquare} Our aim is to perform a comprehensive systematic review of the performance of retinal diagnostic methods, namely OCT, OCTA, CFP, and ERG in neurodegenerative disease subtyping. {blacksquare}We will use the carefully defined methodology in accordance with the Cochrane handbook, and the results of this systematic review will be reported as per Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol (PRISMA-P) statement. {blacksquare}The certainty of this systematic review may be limited due to the small sample of studies for Dementia with Lewy Bodies (DLB), Frontotemporal Dementia (FTD), and Vascular Dementia (VaD).

Authors: Zeynep Sahin, S. Pisani, P. Nderitu, A. V. Venkataraman, T.-W. Guu, D. Aarsland, T. Jackson, D. ffytche

Last Update: 2024-05-27 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.05.27.24306765

Source PDF: https://www.medrxiv.org/content/10.1101/2024.05.27.24306765.full.pdf

Licence: https://creativecommons.org/licenses/by-nc/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

More from authors

Similar Articles